Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.
作者信息
Jouret Maurine, Aguiar Francisca, Girard-Guyonvarc'h Charlotte, Vyzhga Yulia, Oliveira-Ramos Filipa, Lana Cristina Costa, Guedri Rahma, Lefevre-Utile Alain, Hadef Djohra, Angarita Juan Manuel Mosquera, Ozen Seza, Sahin Sezgin, Hashad Soad, Daghor-Abbaci Karima, Foell Dirk, Georgin-Lavialle Sophie, Theodoropoulou Katerina
机构信息
Pediatric Nephrology, Rheumatology, Dermatology Unit, Hospices Civils de Lyon, Lyon, France.
Adult and Pediatric Rheumatology Unit, ULS São JoãoYoung, Porto, Portugal.
出版信息
Rheumatol Adv Pract. 2025 Jul 3;9(3):rkaf073. doi: 10.1093/rap/rkaf073. eCollection 2025.
Abstract
摘要
相似文献
1
Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.JIR-CliPS网络内关于斯蒂尔病肺部受累的临床实践策略（CliPS）的全球评估：一项欧洲科学与技术合作组织（COST）行动
Rheumatol Adv Pract. 2025 Jul 3;9(3):rkaf073. doi: 10.1093/rap/rkaf073. eCollection 2025.
2
Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease.Still 病和巨噬细胞活化综合征（MAS）治疗的疗效和安全性：一项系统评价，为 EULAR/PReS Still 病管理指南提供信息。
Ann Rheum Dis. 2024 Nov 14;83(12):1731-1747. doi: 10.1136/ard-2024-225854.
3
Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials.生物制剂治疗斯蒂尔病的疗效与安全性：一项随机对照试验的系统评价和网状Meta分析
Rheumatology (Oxford). 2025 Jan 1;64(1):22-31. doi: 10.1093/rheumatology/keae295.
4
Advancing Point-of-Care Still's Murmur Identification: Evaluating the Efficacy of ConvNets and Transformers Using the StethAid Multicenter Heart Sound Database.推进即时护理期卡氏杂音识别：使用StethAid多中心心音数据库评估卷积神经网络和变换器的有效性。
IEEE Trans Biomed Eng. 2025 Sep 4;PP. doi: 10.1109/TBME.2025.3606341.
5
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment.应对斯蒂尔病患者的临床异质性，从早期诊断到及时治疗。
Autoimmun Rev. 2025 Jul 18;24(10):103880. doi: 10.1016/j.autrev.2025.103880.
6
Evaluation of clinical biomarkers for differential diagnosis of intravascular lymphoma and Still's disease.用于血管内淋巴瘤和斯蒂尔病鉴别诊断的临床生物标志物评估
Sci Rep. 2025 Jul 4;15(1):23901. doi: 10.1038/s41598-025-09401-4.
7
Coincident Kikuchi-Fujimoto's disease and adult-onset Still's disease: report of a patient from an uncommonly affected population and case-directed systematic review.同时发生的菊池古川病和成人Still 病：来自罕见发病人群的患者报告和病例导向的系统综述。
Clin Rheumatol. 2021 Dec;40(12):4791-4805. doi: 10.1007/s10067-021-05769-6. Epub 2021 Jun 7.
8
Current evidence on switching between biologic therapies for Still's disease: A systematic literature review.关于斯蒂尔病生物治疗转换的当前证据：一项系统文献综述。
Semin Arthritis Rheum. 2025 Oct;74:152789. doi: 10.1016/j.semarthrit.2025.152789. Epub 2025 Jul 18.
9
mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome.mTORC1 将斯蒂尔病和巨噬细胞活化综合征的实验模型中的病理学联系起来。
Nat Commun. 2022 Nov 28;13(1):6915. doi: 10.1038/s41467-022-34480-6.
本文引用的文献
1
The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry.斯蒂尔病患者肺部受累情况的临床评估，来自多中心国际AIDA网络斯蒂尔病登记处的结果。
Rheumatology (Oxford). 2025 Jan 20. doi: 10.1093/rheumatology/keaf021.
2
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.EULAR/PReS 关于斯蒂尔病（包括全身型幼年特发性关节炎和成人斯蒂尔病）的诊断和治疗建议。
Ann Rheum Dis. 2024 Nov 14;83(12):1614-1627. doi: 10.1136/ard-2024-225851.
3
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants.重组白细胞介素-1 受体拮抗剂是新诊断的全身型幼年特发性关节炎的有效一线治疗策略，与 HLA-DRB1 背景和 IL1RN 变异无关。
Arthritis Rheumatol. 2024 Jan;76(1):119-129. doi: 10.1002/art.42656. Epub 2023 Nov 6.
4
Lung Involvement in Systemic Juvenile Idiopathic Arthritis: A Narrative Review.全身型幼年特发性关节炎的肺部受累：一篇叙述性综述。
Diagnostics (Basel). 2022 Dec 8;12(12):3095. doi: 10.3390/diagnostics12123095.
5
Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.成人斯蒂尔病中罕见、更为罕见的肺部受累：一篇综述。
Front Med (Lausanne). 2022 Sep 16;9:989777. doi: 10.3389/fmed.2022.989777. eCollection 2022.
6
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.成人斯蒂尔病中的肺实质疾病：疾病严重程度的一个新出现的标志物——来自意大利临床与实验风湿病研究小组（GIRRCS）患者队列的特征及预测因素
Arthritis Res Ther. 2020 Jun 22;22(1):151. doi: 10.1186/s13075-020-02245-5.
7
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.系统性幼年特发性关节炎相关肺病：特征和危险因素。
Arthritis Rheumatol. 2019 Nov;71(11):1943-1954. doi: 10.1002/art.41073. Epub 2019 Oct 1.
8
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.系统性幼年特发性关节炎中的肺动脉高压和其他潜在致命性肺部并发症。
Arthritis Care Res (Hoboken). 2013 May;65(5):745-52. doi: 10.1002/acr.21889.
Zotero 插件